These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4129 related articles for article (PubMed ID: 4042670)

  • 1. Neck dissection for cancer.
    Ballantyne AJ
    Curr Probl Cancer; 1985 Aug; 9(8):1-34. PubMed ID: 4042670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sun Smart Day: a pilot program for photoprotection education.
    Buller MK; Goldberg G; Buller DB
    Pediatr Dermatol; 1997; 14(4):257-63. PubMed ID: 9263304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion.
    Stern JB; Peck GL; Haupt HM; Hollingsworth HC; Beckerman T
    J Am Acad Dermatol; 1993 Apr; 28(4):591-4. PubMed ID: 8463460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on the ultrastructure of malignant melanoma in fish and human by freeze-etching and transmission electron microscopy.
    Riehl R; Schartl M; Kollinger G
    J Cancer Res Clin Oncol; 1984; 107(1):21-31. PubMed ID: 6699072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin profiles in the mucosa adjacent to large bowel non-adenocarcinoma neoplasias.
    Lapertosa G; Fulcheri E; Acquarone M; Filipe MI
    Histopathology; 1984 Sep; 8(5):805-11. PubMed ID: 6519650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
    Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
    J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival rate of young patients with malignant choroidal melanoma after conservative treatment].
    Romanowska B; Zygulska-Mach H; Ksiezyk M
    Klin Oczna; 1998; 100(4):211-6. PubMed ID: 9770979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic potential and multidrug resistance correlation in the B16 melanoma system.
    Staroselsky AN; Mahlin T; Savion N; Klein O; Nordenberg J; Donin N; Michowitz M; Leibovici J
    J Exp Ther Oncol; 1996 Jul; 1(4):251-9. PubMed ID: 9414412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity for and epigenetic modulation of mdr-1 expression in murine melanoma.
    Yoon SS; Fidler IJ; Beltran PJ; Bucana CD; Wang YF; Fan D
    Melanoma Res; 1997 Aug; 7(4):275-87. PubMed ID: 9293477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intermediate filaments in migration, invasion and metastasis.
    Hendrix MJ; Seftor EA; Chu YW; Trevor KT; Seftor RE
    Cancer Metastasis Rev; 1996 Dec; 15(4):507-25. PubMed ID: 9034607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is involvement of the clitoris in epidermoid carcinoma of the vulva an adverse prognostic sign?].
    Masák L; Hudáková G
    Ceska Gynekol; 1996 Oct; 61(5):299-301. PubMed ID: 9004977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models.
    De Flora S; D'Agostini F; Masiello L; Giunciuglio D; Albini A
    Int J Cancer; 1996 Sep; 67(6):842-8. PubMed ID: 8824557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited value of the NKI/C3-antibody for the differential diagnosis of Paget's disease of the nipple and intra-epidermal malignant melanoma.
    Biesterfeld S; Kusche M; Viereck E; Füzesi L
    Histopathology; 1996 Mar; 28(3):269-70. PubMed ID: 8729049
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome].
    Kharkevich GIu; Kazubskaia TP; Agapova RK; Musatov VK; Trubnikov VI; Demidov LV; Gar'kavtseva RF
    Genetika; 1995 Nov; 31(11):1562-5. PubMed ID: 8666223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience.
    Yannelli JR; Hyatt C; McConnell S; Hines K; Jacknin L; Parker L; Sanders M; Rosenberg SA
    Int J Cancer; 1996 Feb; 65(4):413-21. PubMed ID: 8621219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study.
    Slavik M; Liu PY; Kraut EH; Natale RB; Flaherty LE; Sondak VK
    Invest New Drugs; 1995; 13(2):143-7. PubMed ID: 8617577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity.
    Lilischkis R; Sarcevic B; Kennedy C; Warlters A; Sutherland RL
    Int J Cancer; 1996 Apr; 66(2):249-54. PubMed ID: 8603820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The assessment of tumor blood flow factors using dynamic CT--a comparison with positron emission tomography].
    Miyakawa E
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Mar; 53(3):297-307. PubMed ID: 8474863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced in vitro tumor cell retention and internalization of antibody derivatized with synthetic peptides.
    Anderson DC; Manger R; Schroeder J; Woodle D; Barry M; Morgan AC; Fritzberg AR
    Bioconjug Chem; 1993; 4(1):10-8. PubMed ID: 8431507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous myxoid melanoma: immunohistologic clues to a difficult diagnosis.
    Prieto VG; Kanik A; Salob S; McNutt NS
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 2):335-9. PubMed ID: 8294593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 207.